Identification of a Biomarker Panel in Extracellular Vesicles Derived From Non‐Small Cell Lung Cancer (NSCLC) Through Proteomic Analysis and Machine Learning
Journal of Extracellular Vesicles · 2025-05 · 14 (5)
DOI: 10.1002/jev2.70078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 14.05.2025. Verfasst von Ye Yuan und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, P. R. China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Extracellular Vesicles, Biomarkers, Tumor, Lung Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Antigen fingerprint profiling of tumour‐derived extracellular vesicles (TDEVs) in the body fluids is a promising strategy for identifying tumour biomarkers. In this study, proteomic and immunological assays reveal significantly higher CD155 levels in plasma extracellular vesicles (EVs) from patients with non‐small cell lung cancer (NSCLC) than from healthy individuals. Utilizing CD155 as a bait protein on the EV membrane, CD155+ TDEVs are enriched from NSCLC patient plasma EVs. In the discovery cohort, 281 differentially expressed proteins are identified in TDEVs of the NSCLC group compared with the healthy control group. In the verification cohort, 49 candidate biomarkers are detected using targeted proteomic analysis. Of these, a biomarker panel of seven frequently and stably detected proteins—MVP, GYS1, SERPINA3, HECTD3, SERPING1, TPM4, and APOD—demonstrates good diagnostic performance, achieving an area under the curve (AUC) of 1.0 with 100% sensitivity and specificity in receiver operating characteristic (ROC) curve analysis, and 92.3% sensitivity and 88.9% specificity in confusion matrix analysis. Western blotting results confirm upregulation trends for MVP, GYS1, SERPINA3, HECTD3, SERPING1 and APOD, and TPM4 is downregulated in EVs of NSCLC patients compared with healthy individuals. These findings highlight the potential of this biomarker panel for the clinical diagnosis of NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, P. R. China.
- Key Laboratory of Biomacromolecules (CAS), Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
- Renmin Hospital, Hubei University of Medicine, Shiyan, P. R. China.
- Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, Shenzhen, China.
ORCID-Profile: Xian-En Zhang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Yuan, Y., Jiang, H., Xue, R., Feng, X. J., Liu, B. F., Li, L., Peng, B., Ren, C. S., Li, S. M., Li, N., Li, M., Wang, D. B., & Zhang, X. E. (2025). Identification of a Biomarker Panel in Extracellular Vesicles Derived From Non‐Small Cell Lung Cancer (NSCLC) Through Proteomic Analysis and Machine Learning. Journal of Extracellular Vesicles, 14(5). https://doi.org/10.1002/jev2.70078
Vancouver
Yuan Y, Jiang H, Xue R, Feng XJ, Liu BF, Li L, et al. Identification of a Biomarker Panel in Extracellular Vesicles Derived From Non‐Small Cell Lung Cancer (NSCLC) Through Proteomic Analysis and Machine Learning. Journal of Extracellular Vesicles. 2025;14(5). doi:10.1002/jev2.70078
BibTeX
@article{Yuan2025,
author = {Yuan, Ye and Jiang, Hai and Xue, Rui and Feng, Xiao-Jun and Liu, Bi-Feng and Li, Lian and Peng, Bo and Ren, Chen-Shuo and Li, Shi-Min and Li, Na and Li, Min and Wang, Dian-Bing and Zhang, Xian-En},
title = {Identification of a Biomarker Panel in Extracellular Vesicles Derived From Non‐Small Cell Lung Cancer (NSCLC) Through Proteomic Analysis and Machine Learning},
journal = {Journal of Extracellular Vesicles},
year = {2025},
volume = {14},
number = {5},
doi = {10.1002/jev2.70078}
}
EUVIMED